Sterling Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $859K | Sell |
2,990
-1,825
| -38% | -$524K | 0.01% | 687 |
|
|
2025
Q1 | $1.48M | Sell |
4,815
-1,150
| -19% | -$355K | 0.02% | 461 |
|
|
2024
Q4 | $2.1M | Buy |
5,965
+723
| +14% | +$255K | 0.03% | 392 |
|
|
2024
Q3 | $1.88M | Buy |
+5,242
| New | +$1.88M | 0.02% | 399 |
|
|
2019
Q3 | – | Sell |
-6,287
| Closed | -$491K | – | 927 |
|
|
2019
Q2 | $491K | Sell |
6,287
-20,880
| -77% | -$1.63M | ﹤0.01% | 761 |
|
|
2019
Q1 | $3.19M | Buy |
+27,167
| New | +$3.19M | 0.03% | 315 |
|
|
2017
Q4 | – | Sell |
-18,534
| Closed | -$2.17M | – | 961 |
|
|
2017
Q3 | $2.17M | Buy |
18,534
+1,060
| +6% | +$124K | 0.02% | 392 |
|
|
2017
Q2 | $2.27M | Sell |
17,474
-3,649
| -17% | -$473K | 0.02% | 363 |
|
|
2017
Q1 | $2.86M | Buy |
21,123
+1,080
| +5% | +$146K | 0.03% | 304 |
|
|
2016
Q4 | $2.88M | Buy |
+20,043
| New | +$2.88M | 0.03% | 307 |
|
|
2015
Q4 | – | Sell |
-3,270
| Closed | -$429K | – | 1046 |
|
|
2015
Q3 | $429K | Buy |
+3,270
| New | +$429K | ﹤0.01% | 803 |
|
|
2015
Q2 | – | Sell |
-15,189
| Closed | -$2.62M | – | 943 |
|
|
2015
Q1 | $2.62M | Sell |
15,189
-11,208
| -42% | -$1.93M | 0.02% | 261 |
|
|
2014
Q4 | $3.42M | Sell |
26,397
-328
| -1% | -$42.5K | 0.03% | 246 |
|
|
2014
Q3 | $3.44M | Sell |
26,725
-31
| -0.1% | -$3.99K | 0.04% | 229 |
|
|
2014
Q2 | $2.37M | Buy |
26,756
+308
| +1% | +$27.3K | 0.02% | 294 |
|
|
2014
Q1 | $2.49M | Buy |
26,448
+9,999
| +61% | +$940K | 0.02% | 274 |
|
|
2013
Q4 | $1.86M | Buy |
16,449
+285
| +2% | +$32.2K | 0.02% | 260 |
|
|
2013
Q3 | $1.28M | Buy |
16,164
+11,599
| +254% | +$915K | 0.02% | 226 |
|
|
2013
Q2 | $300K | Buy |
+4,565
| New | +$300K | ﹤0.01% | 511 |
|